Julius Knowles's Insider Trades & SAST Disclosures
Julius Knowles's most recent trade in Keros Therapeutics Inc was a trade of 10,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Julius Knowles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 6,441 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 03 Jan 2022 | 5,236 | 356,408 | - | 59.0 | 308,715 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.83 per share. | 03 Jan 2022 | 5,094 | 361,644 | - | 57.8 | 294,586 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.99 per share. | 03 Jan 2022 | 4,151 | 347,383 | - | 58.0 | 240,716 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.82 per share. | 03 Jan 2022 | 3,678 | 366,738 | - | 56.8 | 208,984 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 03 Jan 2022 | 3,412 | 242,400 | - | 59.0 | 201,172 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.86 per share. | 03 Jan 2022 | 3,367 | 344,016 | - | 58.9 | 198,182 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.83 per share. | 03 Jan 2022 | 3,318 | 245,812 | - | 57.8 | 191,880 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.99 per share. | 03 Jan 2022 | 2,704 | 236,514 | - | 58.0 | 156,805 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.82 per share. | 03 Jan 2022 | 2,406 | 249,130 | - | 56.8 | 136,709 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.86 per share. | 03 Jan 2022 | 2,195 | 234,319 | - | 58.9 | 129,198 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 03 Jan 2022 | 2,124 | 353,241 | - | 56.1 | 119,156 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 03 Jan 2022 | 1,707 | 351,534 | - | 57.0 | 97,214 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 03 Jan 2022 | 1,383 | 240,331 | - | 56.1 | 77,586 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.20 per share. | 03 Jan 2022 | 1,356 | 342,241 | - | 58.2 | 78,919 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 03 Jan 2022 | 1,113 | 239,218 | - | 56.9 | 63,385 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.20 per share. | 03 Jan 2022 | 886 | 233,162 | - | 58.2 | 51,565 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.95 per share. | 03 Jan 2022 | 794 | 355,365 | - | 54.9 | 43,630 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 Jan 2022 | 667 | 341,574 | - | 59 | 39,353 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.95 per share. | 03 Jan 2022 | 524 | 241,714 | - | 55.0 | 28,794 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 Jan 2022 | 435 | 232,727 | - | 59 | 25,665 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.23 per share. | 03 Jan 2022 | 419 | 343,597 | - | 57.2 | 23,979 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.23 per share. | 03 Jan 2022 | 271 | 234,048 | - | 57.2 | 15,509 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 03 Jan 2022 | 249 | 356,159 | - | 59.4 | 14,791 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 03 Jan 2022 | 162 | 242,238 | - | 59.4 | 9,623 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 01 Dec 2021 | 8,747 | 370,554 | - | 53.9 | 471,113 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.17 per share. | 01 Dec 2021 | 6,372 | 379,301 | - | 53.2 | 338,799 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 01 Dec 2021 | 5,705 | 251,626 | - | 53.9 | 307,271 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 5,168 | 389,846 | - | 54.7 | 282,535 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.48 per share. | 01 Dec 2021 | 4,243 | 395,014 | - | 53.5 | 226,916 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.17 per share. | 01 Dec 2021 | 4,155 | 257,331 | - | 53.2 | 220,921 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 3,372 | 264,208 | - | 54.7 | 184,347 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.48 per share. | 01 Dec 2021 | 2,766 | 267,580 | - | 53.5 | 147,926 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 01 Dec 2021 | 2,528 | 387,318 | - | 55.7 | 140,835 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 01 Dec 2021 | 1,649 | 262,559 | - | 55.7 | 91,866 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.27 per share. | 01 Dec 2021 | 1,566 | 385,752 | - | 56.3 | 88,119 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.27 per share. | 01 Dec 2021 | 1,021 | 261,538 | - | 56.3 | 57,452 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 138 | 370,416 | - | 54.7 | 7,544 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 90 | 251,536 | - | 54.7 | 4,920 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 51.99 per share. | 01 Dec 2021 | 79 | 385,673 | - | 52.0 | 4,107 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 52.00 per share. | 01 Dec 2021 | 52 | 261,486 | - | 52 | 2,704 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 01 Nov 2021 | 7,350 | 413,691 | - | 42.4 | 311,861 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.85 per share. | 01 Nov 2021 | 7,057 | 421,041 | - | 41.8 | 295,335 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 01 Nov 2021 | 6,067 | 402,854 | - | 41.7 | 252,691 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 01 Nov 2021 | 4,797 | 279,760 | - | 42.4 | 203,537 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.85 per share. | 01 Nov 2021 | 4,599 | 284,557 | - | 41.8 | 192,468 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 01 Nov 2021 | 3,957 | 272,692 | - | 41.6 | 164,809 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 01 Nov 2021 | 3,597 | 399,257 | - | 42.5 | 152,693 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Nov 2021 | 3,252 | 410,439 | - | 42.1 | 136,909 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 01 Nov 2021 | 2,346 | 270,346 | - | 42.5 | 99,588 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Nov 2021 | 2,120 | 277,640 | - | 42.1 | 89,252 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 01 Nov 2021 | 1,518 | 408,921 | - | 43.0 | 65,335 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 01 Nov 2021 | 991 | 276,649 | - | 43.0 | 42,653 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 19 Oct 2021 | 2,242 | 428,098 | - | 38.3 | 85,891 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.05 per share. | 19 Oct 2021 | 2,029 | 431,273 | - | 38.0 | 77,203 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 19 Oct 2021 | 1,463 | 289,156 | - | 38.3 | 56,048 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.05 per share. | 19 Oct 2021 | 1,323 | 291,227 | - | 38.0 | 50,340 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.49 per share. | 19 Oct 2021 | 704 | 430,569 | - | 38.5 | 27,097 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.49 per share. | 19 Oct 2021 | 460 | 290,767 | - | 38.5 | 17,705 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 37.55 per share. | 19 Oct 2021 | 229 | 430,340 | - | 37.6 | 8,599 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 37.55 per share. | 19 Oct 2021 | 148 | 290,619 | - | 37.5 | 5,557 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 37.69 per share. | 14 Oct 2021 | 8,252 | 433,394 | - | 37.7 | 311,018 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 37.69 per share. | 14 Oct 2021 | 5,382 | 292,610 | - | 37.7 | 202,848 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.95 per share. | 14 Oct 2021 | 3,031 | 443,577 | - | 38.9 | 118,057 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 14 Oct 2021 | 2,653 | 446,608 | - | 40.1 | 106,465 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.95 per share. | 14 Oct 2021 | 1,977 | 299,251 | - | 38.9 | 77,004 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 39.44 per share. | 14 Oct 2021 | 1,839 | 441,738 | - | 39.4 | 72,530 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.13 per share. | 14 Oct 2021 | 1,730 | 301,228 | - | 40.1 | 69,425 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 39.44 per share. | 14 Oct 2021 | 1,199 | 298,052 | - | 39.4 | 47,289 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.46 per share. | 14 Oct 2021 | 92 | 433,302 | - | 38.5 | 3,538 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 14 Oct 2021 | 92 | 441,646 | - | 40.6 | 3,735 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 14 Oct 2021 | 60 | 292,550 | - | 38.5 | 2,308 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 14 Oct 2021 | 60 | 297,992 | - | 40.6 | 2,436 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.16 per share. | 01 Oct 2021 | 3,827 | 453,112 | - | 40.2 | 153,692 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.16 per share. | 01 Oct 2021 | 2,496 | 305,470 | - | 40.2 | 100,239 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 01 Oct 2021 | 2,267 | 450,845 | - | 40.1 | 90,816 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 01 Oct 2021 | 1,584 | 449,261 | - | 40.0 | 63,408 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 01 Oct 2021 | 1,479 | 303,991 | - | 40.1 | 59,249 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 01 Oct 2021 | 1,033 | 302,958 | - | 40.0 | 41,351 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 27 Sep 2021 | 27,373 | 487,249 | - | 40.5 | 1,108,880 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 27 Sep 2021 | 20,292 | 466,957 | - | 41.5 | 842,524 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 27 Sep 2021 | 17,854 | 327,731 | - | 40.5 | 723,266 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.52 per share. | 27 Sep 2021 | 13,233 | 314,498 | - | 41.5 | 549,434 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.29 per share. | 27 Sep 2021 | 10,018 | 456,939 | - | 42.3 | 423,661 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.29 per share. | 27 Sep 2021 | 6,532 | 307,966 | - | 42.3 | 276,238 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.22 per share. | 01 Jul 2021 | 13,268 | 530,196 | - | 41.2 | 546,907 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.22 per share. | 01 Jul 2021 | 8,650 | 355,745 | - | 41.2 | 356,553 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 01 Jul 2021 | 8,627 | 520,411 | - | 41.1 | 354,397 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.72 per share. | 01 Jul 2021 | 5,789 | 514,622 | - | 41.7 | 241,517 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 01 Jul 2021 | 5,626 | 349,361 | - | 41.1 | 231,116 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.72 per share. | 01 Jul 2021 | 3,776 | 345,585 | - | 41.7 | 157,535 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.89 per share. | 01 Jul 2021 | 1,112 | 529,084 | - | 41.9 | 46,582 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.89 per share. | 01 Jul 2021 | 728 | 355,017 | - | 41.9 | 30,496 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.76 per share. | 01 Jul 2021 | 46 | 529,038 | - | 42.8 | 1,967 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.77 per share. | 01 Jul 2021 | 30 | 354,987 | - | 42.8 | 1,283 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 50.80 per share. | 04 Jun 2021 | 3,968 | 544,322 | - | 50.8 | 201,574 | Common Stock |
| Keros Therapeutics Inc | Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 47.23 per share. | 04 Jun 2021 | 2,988 | 552,227 | - | 47.2 | 141,123 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges